Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 2
1986 1
1988 2
1989 29
1990 5
1991 4
1992 28
1993 13
1994 18
1995 17
1996 28
1997 45
1998 42
1999 49
2000 52
2001 58
2002 74
2003 67
2004 83
2005 66
2006 69
2007 73
2008 56
2009 54
2010 43
2011 41
2012 38
2013 39
2014 27
2015 31
2016 18
2017 17
2018 17
2019 8
2020 7
2021 15
2022 7
2023 6
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,156 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Dapoxetine /Tadalafil and Paroxetine/Tadalafil Combination Therapies for the Treatment of the Premature Ejaculation: A Randomized Clinical Trial.
Mohseni Rad H, Zahirian Moghadam T, Hosseinkhani A, Nima Soluki N, Amani F. Mohseni Rad H, et al. Urol J. 2021 Nov 13;19(2):138-143. doi: 10.22037/uj.v18i.6644. Urol J. 2021. PMID: 34773634 Free article. Clinical Trial.
PURPOSE: The purpose of this study was to compare the effectiveness of Dapoxetine, and Paroxetine as well as Dapoxetine/Tadalafil and Paroxetine/Tadalafil combinational therapies, for the treatment of patients with premature ejaculation. MATERIALS AND METHODS: In th …
PURPOSE: The purpose of this study was to compare the effectiveness of Dapoxetine, and Paroxetine as well as Dapoxetine/Tadalafil and …
Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial.
Wang B, Huang Y, Tang Y, Zhao Z, Shi W, Jian D, Liu F, Gao Q, Wang P, Yang J, Li L, Xie H, Li J. Wang B, et al. J Am Acad Dermatol. 2023 Jun;88(6):1300-1307. doi: 10.1016/j.jaad.2023.01.044. Epub 2023 Feb 15. J Am Acad Dermatol. 2023. PMID: 36806645 Clinical Trial.
The most reported adverse events associated with paroxetine were dizziness, lethargy, nausea, dyspepsia, and muscle tremors. LIMITATIONS: Only a single-dosage regimen of paroxetine within a 12-week study was evaluated. CONCLUSIONS: Paroxetine is an effective …
The most reported adverse events associated with paroxetine were dizziness, lethargy, nausea, dyspepsia, and muscle tremors. LIMITATI …
Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
Nardi AE, Valença AM, Freire RC, Mochcovitch MD, Amrein R, Sardinha A, Levitan MN, Nascimento I, de-Melo-Neto VL, King AL, de O E Silva AC, Veras AB, Dias GP, Soares-Filho GL, da Costa RT, Mezzasalma MA, de Carvalho MR, de Cerqueira AC, Hallak JE, Crippa JA, Versiani M. Nardi AE, et al. Braz J Med Biol Res. 2011 Apr;44(4):366-73. doi: 10.1590/s0100-879x2011007500020. Epub 2011 Feb 18. Braz J Med Biol Res. 2011. PMID: 21344132 Free article. Clinical Trial.
Most patients were females (69.8 and 68.4% in the clonazepam and paroxetine groups, respectively) and age (mean SD) was 35.9 9.6 years for the clonazepam group and 33.7 8.8 years for the paroxetine group. ...Anxiety severity was significantly reduced with clonazepam …
Most patients were females (69.8 and 68.4% in the clonazepam and paroxetine groups, respectively) and age (mean SD) was 35.9 9.6 year …
A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults.
Weiss M, Hechtman L; Adult ADHD Research Group. Weiss M, et al. J Clin Psychiatry. 2006 Apr;67(4):611-9. J Clin Psychiatry. 2006. PMID: 16669726 Clinical Trial.
OBJECTIVE: To determine the effect of psychotherapy, dextroamphetamine, and/or paroxetine on attention-deficit/hyperactivity-disorder (ADHD) in adults. METHOD: Ninety-eight adults with DSM-IV ADHD were randomly assigned to receive psychotherapy and dextroamphetamine, pa …
OBJECTIVE: To determine the effect of psychotherapy, dextroamphetamine, and/or paroxetine on attention-deficit/hyperactivity-disorder …
Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial.
Abu El-Hamd M, Abdelhamed A. Abu El-Hamd M, et al. Andrologia. 2018 Feb;50(1). doi: 10.1111/and.12829. Epub 2017 May 12. Andrologia. 2018. PMID: 28497478 Clinical Trial.
The aim of the study was to compare the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation (PE). ...The combined dapoxetine with sildenafil ther …
The aim of the study was to compare the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and c …
Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial.
Langemark M, Olesen J. Langemark M, et al. Headache. 1994 Jan;34(1):20-4. doi: 10.1111/j.1526-4610.1994.hed3401020.x. Headache. 1994. PMID: 8132436 Clinical Trial.
Group comparison of 24 patients first treated with paroxetine and 24 patients first treated with sulpiride showed a non-significant trend in favor of sulpiride by 'Global' evaluation and by evaluation of the available diary records (18 paroxetine-treated and 19 sulp …
Group comparison of 24 patients first treated with paroxetine and 24 patients first treated with sulpiride showed a non-significant t …
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.
Pollack M, Mangano R, Entsuah R, Tzanis E, Simon NM, Zhang Y. Pollack M, et al. Psychopharmacology (Berl). 2007 Oct;194(2):233-42. doi: 10.1007/s00213-007-0821-0. Epub 2007 Jun 23. Psychopharmacology (Berl). 2007. PMID: 17589833 Clinical Trial.
Secondary objectives included comparing paroxetine with venlafaxine ER and placebo. METHODS: Outpatients aged > or =18 years (placebo, n = 157; venlafaxine ER 75 mg, n = 156; venlafaxine ER 225 mg, n = 160; paroxetine, n = 151), with a primary diagnosis of panic …
Secondary objectives included comparing paroxetine with venlafaxine ER and placebo. METHODS: Outpatients aged > or =18 years (plac …
Paroxetine, Cognitive Therapy or Their Combination in the Treatment of Social Anxiety Disorder with and without Avoidant Personality Disorder: A Randomized Clinical Trial.
Nordahl HM, Vogel PA, Morken G, Stiles TC, Sandvik P, Wells A. Nordahl HM, et al. Psychother Psychosom. 2016;85(6):346-356. doi: 10.1159/000447013. Epub 2016 Oct 15. Psychother Psychosom. 2016. PMID: 27744447 Free article. Clinical Trial.
METHODS: A total of 102 patients were randomly assigned to paroxetine, CT, the combination of CT and paroxetine, or pill placebo. The medication treatment lasted 26 weeks. ...At the 12-month follow-up, the CT group maintained benefits and was significantly better th …
METHODS: A total of 102 patients were randomly assigned to paroxetine, CT, the combination of CT and paroxetine, or pill place …
A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
Vieta E, Martinez-Arán A, Goikolea JM, Torrent C, Colom F, Benabarre A, Reinares M. Vieta E, et al. J Clin Psychiatry. 2002 Jun;63(6):508-12. doi: 10.4088/jcp.v63n0607. J Clin Psychiatry. 2002. PMID: 12088162 Clinical Trial.
By intention-to-treat analysis, 43% (N = 13) of patients taking paroxetine and 48% (N = 14) taking venlafaxine were considered to be responders. Only 3% (N = 1) of patients switched to hypomania or mania in the paroxetine group, whereas 13% (N = 4) switched in the v …
By intention-to-treat analysis, 43% (N = 13) of patients taking paroxetine and 48% (N = 14) taking venlafaxine were considered to be …
Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers.
Schoedel KA, Pope LE, Sellers EM. Schoedel KA, et al. Clin Drug Investig. 2012 Mar 1;32(3):157-69. doi: 10.2165/11599870-000000000-00000. Clin Drug Investig. 2012. PMID: 22283559 Clinical Trial.
In group 1 (n = 14), addition of DMQ to paroxetine resulted in a 30% increase in mean plasma exposure of paroxetine (AUC up to 24 hours). ...The incidence of AEs was higher with paroxetine monotherapy and combination therapy, compared with DMQ given alone (30 …
In group 1 (n = 14), addition of DMQ to paroxetine resulted in a 30% increase in mean plasma exposure of paroxetine (AUC up to …
1,156 results